Acthar pulmonary studies

Discussion in 'Mallinckrodt' started by anonymous, Sep 11, 2019 at 12:21 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Found out yesterday from one of customers sharing this that they are not paying sites any longer for enrolling patients on Acthar! Even those that had already been enrolled awhile back. This is really bad for business. Shouldn’t been done anyway.
     

  2. anonymous

    anonymous Guest

    FAKE NEWS!!!
     
  3. anonymous

    anonymous Guest

    thats actually very illegal and not true at all
     
  4. anonymous

    anonymous Guest

    No surprise here
     
  5. anonymous

    anonymous Guest

    Correction: If it’s illegal, then you know it’s true!
     
  6. anonymous

    anonymous Guest

    It’s more important to pay Mark 15 million a year than provide evidence.
     
  7. anonymous

    anonymous Guest


    The studies were always a farce. They have no intentions of producing a single piece of relevant data. Most studied will never see the light of day. This video is from 2016. Please watch this video below. MT squirms while he’s answering questions. We have no creditable data on the market in any therapeutic area and you can tell he knows.



    www.cnbc.com/amp/2016/03/15/short-seller-and-mallinckrodt-ceo-go-head-to-head.html
     
  8. anonymous

    anonymous Guest

    You are spot on! Some companies sponsor their own studies as a way to give doctors a “legal” kick back. When what they need is a kick in the rear. Affirmative of this for example
    Is a practitioner who never used and saw no benefit in using until
    paid to use as in this case.
     
  9. anonymous

    anonymous Guest

    The REAL farce are the doctors who hate mnk amd acthar and then when the company comes to them with money on a silver tray to enroll some sucker patient, omg, then acthar is wonderful! Companies like mnk and skum
    Doctors like these is what is wrong with our healthcare.
     
  10. anonymous

    anonymous Guest

    haha...your link is called short sellers...you loser....eat shit dirt bag
     
  11. anonymous

    anonymous Guest

    Well looking back at the video... who was more accurate at predicting Mallinfraud’s future Mr. Trudeau or Mr. Left?
     
  12. anonymous

    anonymous Guest

    exactly. Imagine how much Andrew made on this piece of shti company. More than Trudeau. That’s for sure. Thatvideo was fantastic. Trudeau is still the same douche
     
  13. anonymous

    anonymous Guest

    Mark needs to pay for his inept and felonious management of MNK.
     
  14. anonymous

    anonymous Guest

    After watching that video and a few others of Mark T, it is shocking he has not gotten charged and arrested for securities fraud. Lie after lie after lie. Even back in 2015 he was touting “great dialogue with payers regarding acktar” That’s the same story he’s telling now, 4 years later, with actually little to no private payers covering acktar. Lied about Medicare reimbursements income vs private payer. Those same studies he claims Mallinfraud were doing are nowhere to be seen. How is this guy still employed and not in jail?
     
  15. anonymous

    anonymous Guest

    Mark is the scum of this industry. The lowest of the low
     
  16. anonymous

    anonymous Guest

    Lock him up!!! The bastard deserves to be in jail for a long time.
     
  17. anonymous

    anonymous Guest

    "We have a solid balance sheet. Very strong cash flow," he added. "We actually raised earnings per share guidance for the year. So, we've been delivering consistently and exceeding shareholder expectations. We have a very strong, solid business model. Well-diversified with excellent brands we're investing in and driving value across the board." -MT

    Still, Left argued that you could take Trudeau's exact response and "take the word Mallinckrodt out and put Valeant in."

    Left was wrong. Mallinckrodt is worse. He forgot one piece of the business; opioids.
     
  18. anonymous

    anonymous Guest

    left made millions on this oversight of his. He still bet this stock was going to tank which it has
     
  19. anonymous

    anonymous Guest

    acthar will get crushed in reorg. Crushed. From sales to marketing and across all functions that support it. Absolutely crushed. It’s not going to be pretty
     
  20. anonymous

    anonymous Guest

    trust me that pulm and rheum team are bored as hell. No one does shti over there but talk all day